|
|||||
|
|
A clinical audit of high‐cost and off‐label drug use in dermatology |
|
| Authors: | Natalie Ong Erin McMeniman Peter Pillans H Peter Soyer |
| Affiliation: | 1. Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia;2. Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Australia;3. Department of Clinical Pharmacology, Princess Alexandra Hospital, Brisbane, Australia |
| Abstract: | |
| Keywords: | adalimumab biologic agent clinical audit cyclosporin dermatology drug infliximab mycophenolate mofetil rituximab thalidomide |